Inhibition of intestinal carcinogenesis by dietary supplementation with calcium
β Scribed by G. V. N. Appleton; P. W. Davies; J. B. Bristol; Professor R. C. N. Williamson
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 378 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Dietary supplementation with calcium reduces colonic crypt cell production rates in both normal and hyperplastic mucosa. Calcium can bind intraluminally with bile salts and fatty acids thus reducing their mitogenic effect. The protective role of oral calcium on intestinal carcinogenesis (induced by azoxymethane) was tested in 60 male Sprague-Dawley rats submitted to either 80 per cent mid jejuno-ileal resection (n = 30) or jejunal transection (n = 30). Half the rats in each group received calcium lactate 24 g/l added to their drinking water. Rats were killed 25-27 weeks postoperatively. Enterectomy increased colonic tumour yield by 60β106 per cent (P = 0Β·002β0Β·005) and duodenal tumour yield by 70β86 per cent. Calcium abolished this effect at both sites, halving intestinal tumour yields in rats with both transection and resection (P<0.05). Doubling the dietary intake of calcium inhibits experimental carcinogenesis.
π SIMILAR VOLUMES
Dietary energy restriction (DER) is a potent inhibitor of mammary carcinogenesis, but the responsible mechanisms are not fully understood. In a number of model systems, DER is associated with a decrease in circulating levels of IGF-1. Moreover, we have recently reported that protection against cance
## Abstract __In situ__ intestinal absorption of baclofen in the rat in the presence of betaβalanine has been investigated. Through the perfusion of 0Β·50 mM baclofen solutions containing variable concentrations of the aminoacid (from 5 to 100 mM), a partially competitive inhibition of baclofen abso